Janney Montgomery Scott LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1329948 PHILADELPHIA, PA

Position in KRYS

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$858,186

+$297,632 QoQ

Shares Held

2,309

+6.4% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#205

of 419 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. KRYS ranks #26 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	85,735	$42,587,146
2	SPRY	ARS Pharmaceuticals, Inc.	2,064,498	$16,536,628
3	REGN	Regeneron Pharmaceuticals, Inc.	12,176	$7,592,223
4	INCY	Incyte Corp	52,727	$5,977,132
5	EXEL	Exelixis, Inc.	89,664	$4,878,618
6	ZVRA	Zevra Therapeutics, Inc.	272,194	$3,903,261
7	AXSM	Axsome Therapeutics, Inc.	13,087	$3,203,304
8	ROIV	Roivant Sciences Ltd.	79,550	$2,815,274

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$858,186	2,309	+6.4%	Shares	Sole	2026-08-05
2026-03-31	$560,554	2,170	-9.5%	Shares	Sole	2026-04-22
2025-12-31	$591,202	2,398	-7.1%	Shares	Sole	2026-02-11
2025-09-30	$455,447	2,580	+10.3%	Shares	Sole	2025-10-27
2025-06-30	$321,656	2,340	-94.9%	Shares	Sole	2025-07-17
2025-03-31	$8,282,080	45,935	-12.7%	Shares	Sole	2025-04-17
2024-12-31	$8,239,062	52,592	+42.0%	Shares	Sole	2025-01-17
2024-09-30	$6,743,665	37,047	+17.1%	Shares	Sole	2024-10-29
2024-06-30	$5,808,900	31,632	+77.3%	Shares	Sole	2024-07-25
2024-03-31	$3,174,804	17,843	+437.4%	Shares	Sole	2024-05-01
2023-06-30	$389,768	3,320	—	Shares	Sole	2023-07-26
No filing history on record for this holder in this stock.